$3,500.00
The leading business intelligence provider GBI Research has released its latest research report, entitled “Travel Vaccines Market to 2019 – Hepatitis A, Japanese Encephalitis and Meningococcal Vaccine.....
Published: May-2013
|
$3,500.00
The leading business intelligence provider GBI Research has released its latest research report, entitled “Adult and Adolescent Vaccines Market to 2018”.
The report provides insights into the vaccin.....
Published: Apr-2013
|
$3,500.00
GBI Research, the leading business intelligence provider has released its latest research “Seasonal Influenza Vaccine Market in Asia-Pacific to 2018 - Positive Impact of Government Support Offset by L.....
Published: Apr-2013
|
$3,500.00
The leading business intelligence provider GBI Research has released its latest research report, entitled “HIV/AIDS Therapeutics Market to 2018 – Despite Major Patent Expiries, Increased Uptake of Onc.....
Published: Nov-2012
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research “Hepatitis C Therapeutics Market to 2018 - Expected Launch of GS-7977 in 2015 will Pave the Way for an Oral I.....
Published: Oct-2012
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research, “Seasonal Influenza Vaccine Market in Top Seven Countries - Next Generation Quadrivalent Vaccines to Dominat.....
Published: Oct-2012
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest report, “Antibacterials Market to 2017 - Innovative Anti-infectives that Target MDR Gram-negative Pathogens Offer Sign.....
Published: May-2012
|
$3,500.00
GBI Research's report "Herpes Market to 2018 – Genericization Compels Competitors Seeking Differentiation to Adopt Novel Drug Delivery Technologies" finds that the global herpes market is an attractiv.....
Published: Apr-2012
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research “Antivirals Market to 2017 - Increased Uptake of High Priced Combination Drugs will Offset the Impact of Gene.....
Published: Apr-2012
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research, “Pediatric Vaccines Market to 2017 – Strategic Focus on Partnering as Licensing and Co-Development Accounted.....
Published: Mar-2012
|
$3,500.00
GBI Research’s new report, “Hepatitis Market to 2017 - Strong Hepatitis-C Pipeline, Large Number of Strategic Consolidations and Cost Effective Treatments will Drive the Market”, provides in-depth ana.....
Published: Jan-2012
|
$3,500.00
GBI Research, the leading business intelligence provider has released its latest research “Antifungals Market to 2017 - Generic Erosion of Major Polyenes, Azoles, Allylamines and Echinocandins to Slow.....
Published: Jan-2012
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research, “Veterinary Vaccines Market to 2017 - Europe to Strengthen Its Position as the Single Largest Market for Ani.....
Published: Jan-2012
|
$3,500.00
GBI Research, the leading business intelligence provider has released its latest research “Seasonal Influenza Vaccine Market in Asia-Pacific Region – Cell Culture Technology-Based Vaccines to Revoluti.....
Published: Dec-2011
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research “Hospital Acquired Bacterial Infections Market to 2017- Niche Players are Most Active in R&D, Positioning The.....
Published: Dec-2011
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research, “Emerging Cancer Vaccines Market to 2017 – Novel, First-In-Class Vaccines in Phase II and Phase III Pipeline.....
Published: Nov-2011
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research, “HIV/AIDS Therapeutics Market to 2017 - Superior Combination Therapies and Decreasing Mortality to Sustain M.....
Published: Oct-2011
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research, “Adult and Adolescent Vaccines Market to 2017 – Partnerships Increase as Licensing and Co-Development Accoun.....
Published: Aug-2011
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research, “Travel Vaccines Market to 2017 – Growth in International Travel and Higher Incidences of Infectious Disease.....
Published: Apr-2011
|
$3,500.00
GBI Research has released its pharmaceutical research, “Anti-Bacterials Market to 2016 - Cephalosporins, Penicillins, Macrolides and Fluoroquinolones to Drive the Anti-Bacterials Market”, which provid.....
Published: Feb-2011
|
$3,500.00
GBI Research has released its latest research “Bone and Joint Infection Market to 2016- Medical Imaging and PCR Methods to Facilitate Early Diagnosis and Treatment”, which essentially provides insight.....
Published: Feb-2011
|
$3,500.00
GBI Research, a leading business intelligence provider, has released its latest research “Antifungals Market to 2016 - Promising Antifungals in Pipeline Includes Novel Azoles, Polyenes and Echinocandi.....
Published: Jan-2011
|
$3,500.00
GBI Research has released its latest research “Antivirals Market to 2016 - Antiretroviral Agents and Combination Therapies to be Major Drivers for the HIV and Hepatitis C Markets”, which essentially p.....
Published: Jan-2011
|
$3,500.00
GBI Research, the leading business intelligence provider has released its latest research “Seasonal Influenza Vaccine Market in Asia-Pacific Region-Threat of Pandemic Influenza and Increasing Vaccinat.....
Published: Dec-2010
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research “Hospital Acquired Bacterial Infections Market to 2016 - Increasing Antibiotic Resistance and Increasing Popu.....
Published: Dec-2010
|